Impact of Dependent Coverage Insurance Expansion on Early Testicular Cancer Diagnosis

2021 ◽  
Vol 8 (1) ◽  
pp. 8-10
Author(s):  
Scott R. Hawken ◽  
Parth K. Modi ◽  
Lindsey A. Herrel
Keyword(s):  
Testicular Cancer ◽  
Cancer Diagnosis ◽  
Dependent Coverage

scholarly journals MP29-15 IMPACT OF DEPENDENT COVERAGE INSURANCE EXPANSION ON EARLY TESTICULAR CANCER DIAGNOSIS

2019 ◽  
Vol 201 (Supplement 4) ◽  
Author(s):  
Scott R. Hawken ◽  
Parth K. Modi ◽  
Lindsey A. Herrel
Keyword(s):  
Testicular Cancer ◽  
Cancer Diagnosis ◽  
Dependent Coverage

scholarly journals Insurance coverage, stage at diagnosis, and time to treatment following dependent coverage and Medicaid expansion for men with testicular cancer

PLoS ONE ◽  
2020 ◽  
Vol 15 (9) ◽  
pp. e0238813
Author(s):  
Adam B. Weiner ◽  
Stephen Jan ◽  
Ketan Jain-Poster ◽  
Oliver S. Ko ◽  
Anuj S. Desai ◽  
...  
Keyword(s):  
Testicular Cancer ◽  
Insurance Coverage ◽  
Medicaid Expansion ◽  
Stage At Diagnosis ◽  
Time To Treatment ◽  
Dependent Coverage

Fertility patterns prior to testicular cancer diagnosis

2005 ◽  
Vol 16 (3) ◽  
pp. 295-299 ◽  
Author(s):  
Julie A. Baker ◽  
Germaine M. Buck ◽  
John E. Vena ◽  
Kirsten B. Moysich
Keyword(s):  
Testicular Cancer ◽  
Cancer Diagnosis

MicroRNAs in Testicular Cancer Diagnosis and Prognosis

2016 ◽  
Vol 43 (1) ◽  
pp. 127-134 ◽  
Author(s):  
Hui Ling ◽  
Lisa Krassnig ◽  
Marc D. Bullock ◽  
Martin Pichler
Keyword(s):  
Testicular Cancer ◽  
Cancer Diagnosis ◽  
Diagnosis And Prognosis ◽  
Cancer Diagnosis And Prognosis

scholarly journals Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillance

2011 ◽  
pp. 1 ◽  
Author(s):  
Jeffrey Montgomery ◽  
Alon Weizer ◽  
Chris Filson ◽  
Jaclyn Milose ◽  
Khaled Hafez
Keyword(s):  
Testicular Cancer ◽  
Cancer Diagnosis ◽  
Biochemical Markers

scholarly journals Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillance

2011 ◽  
Vol Volume 4 ◽  
pp. 1-8
Author(s):  
Jeffrey Montgomery ◽  
Alon Weizer ◽  
Chris Filson ◽  
Jaclyn Milose ◽  
Khaled Hafez
Keyword(s):  
Testicular Cancer ◽  
Cancer Diagnosis ◽  
Biochemical Markers

scholarly journals Quality of life among germ-cell testicular cancer survivors: The effect of time since cancer diagnosis

PLoS ONE ◽  
2021 ◽  
Vol 16 (10) ◽  
pp. e0258257
Author(s):  
Aleksandar Jovanovski ◽  
Daniela Zugna ◽  
Daniela Di Cuonzo ◽  
Patrizia Lista ◽  
Libero Ciuffreda ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Testicular Cancer ◽  
Cancer Survivors ◽  
Germ Cell ◽  
Cancer Patients ◽  
Cancer Diagnosis ◽  
Short Form ◽  
Component Score ◽  
Testicular Cancer Survivors

Introduction Testicular cancer is one of the most treatable cancers, with a 10-year survival of more than 95%. Many patients will be long-term survivors and this disease strikes men in an important phase of their lives, therefore the quality of life (QoL) among these patients is an area of particular interest. We aimed to study whether QoL in testicular cancer survivors depends on the time since cancer diagnosis. Methods Data were collected from the EPSAM (Esposizioni postnatali e salute maschile) study, a case-control study on patients with testicular cancer, diagnosed between 1997 and 2008 in the province of Turin, Northern Italy, and interviewed between 2008 and 2010 (response rate among cases 57%). Patients were contacted through their oncologist at the San Giovanni Batista Hospital in Turin or through their general practitioner (GP) in the rest of the Province of Turin. QoL was assessed cross-sectionally using the short form 12 (SF-12) questionnaire, a generic short-form health survey that produces two summary scores, PCS (physical component score) and MCS (mental component score), to evaluate physical and mental health, respectively. Results Out of 234 study patients, 125 cases were seminomas and 109 cases were nonseminomas. The mean age at diagnosis was 34.5 years. After adjusting for age, time since diagnosis was not associated with PCS and MCS scores. Among nonseminomas, the median PCS slightly increased (adjusted OR (odds ratio) for 5+ vs < 2 years since cancer diagnosis: 1.78 (1.17–2.73), p = 0.008) and MCS slightly decreased (adjusted OR per 1-year increase since cancer diagnosis: 0.92, 95% CI: 0.82–1.05, p = 0.23) with time. Similar findings of no association between time since diagnosis and PCS and MCS were found when the analyses were restricted to the subgroup of cancer patients contacted through their oncologist, whose response proportion was 82%. Conclusion In a study of testicular cancer patients interviewed cross-sectionally at 1 to more than 10 years since diagnosis, time since cancer diagnosis was not associated with QoL when we considered all germ-cell testicular cancer patients together. When stratified by histology type, we found certain evidence that nonseminoma cases report higher PCS over time since cancer diagnosis.

scholarly journals The Role of Imaging in Testicular Cancer Diagnosis, Staging and Follow-up

2017 ◽  
Vol 16 (2) ◽  
pp. 51-56
Author(s):  
Nuray Voyvoda ◽  
Bekir Voyvoda ◽  
Özden Çamurdan
Keyword(s):  
Testicular Cancer ◽  
Cancer Diagnosis

Testicular cancer – diagnosis and treatment

2008 ◽  
Vol 149 (19) ◽  
pp. 894-896 ◽  
Author(s):  
Miklós Szűcs ◽  
Péter Riesz ◽  
Stelios Mavrogenis ◽  
Imre Romics
Keyword(s):  
Testicular Cancer ◽  
Cancer Diagnosis ◽  
Diagnosis And Treatment
Sign in / Sign up

Export Citation Format

Share Document